1. Home
  2. SBET vs EVO Comparison

SBET vs EVO Comparison

Compare SBET & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SharpLink Gaming Ltd.

SBET

SharpLink Gaming Ltd.

HOLD

Current Price

$6.36

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.92

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBET
EVO
Founded
1995
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
SBET
EVO
Price
$6.36
$1.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$18.71
$7.00
AVG Volume (30 Days)
9.0M
45.5K
Earning Date
05-11-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$28,055,000.00
N/A
Revenue This Year
$105.19
$1.37
Revenue Next Year
$13.53
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
666.04
N/A
52 Week Low
$4.46
$1.94
52 Week High
$28.26
$4.32

Technical Indicators

Market Signals
Indicator
SBET
EVO
Relative Strength Index (RSI) 57.73 25.42
Support Level $6.05 N/A
Resistance Level $8.20 $3.36
Average True Range (ATR) 0.32 0.09
MACD 0.08 -0.04
Stochastic Oscillator 79.62 1.51

Price Performance

Historical Comparison
SBET
EVO

About SBET SharpLink Gaming Ltd.

SharpLink Inc is one of those publicly traded companies to adopt ETH as its primary treasury reserve asset. This move reflects the Company's commitment to align corporate treasury with the future of programmable finance, digital capital markets, and decentralized infrastructure. The Company also operates an online affiliate marketing company that delivers different fan activation solutions to its sportsbook and online casino gaming partners. The company operates in two reportable segments: ETH Treasury Management and Affiliate Marketing. The majority of its revenue is generated from the ETH Treasury Management. Geographically, the company operates in the United States and the rest of the world.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: